Growth Metrics

Veracyte (VCYT) Receivables - Net (2016 - 2025)

Veracyte's Receivables - Net history spans 14 years, with the latest figure at $44.7 million for Q4 2025.

  • For Q4 2025, Receivables - Net fell 4.01% year-over-year to $44.7 million; the TTM value through Dec 2025 reached $44.7 million, down 4.01%, while the annual FY2025 figure was $44.7 million, 4.01% down from the prior year.
  • Receivables - Net for Q4 2025 was $44.7 million at Veracyte, down from $47.8 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $53.8 million in Q1 2025 and bottomed at $27.9 million in Q1 2021.
  • The 5-year median for Receivables - Net is $43.3 million (2022), against an average of $43.3 million.
  • The largest annual shift saw Receivables - Net surged 128.65% in 2021 before it decreased 8.28% in 2023.
  • A 5-year view of Receivables - Net shows it stood at $41.5 million in 2021, then increased by 6.17% to $44.0 million in 2022, then decreased by 8.28% to $40.4 million in 2023, then grew by 15.22% to $46.5 million in 2024, then dropped by 4.01% to $44.7 million in 2025.
  • Per Business Quant, the three most recent readings for VCYT's Receivables - Net are $44.7 million (Q4 2025), $47.8 million (Q3 2025), and $50.8 million (Q2 2025).